Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for ...

ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 /Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company ...